System and method for variable depth ultrasound treatment

Information

  • Patent Grant
  • 10039938
  • Patent Number
    10,039,938
  • Date Filed
    Tuesday, April 29, 2014
    10 years ago
  • Date Issued
    Tuesday, August 7, 2018
    5 years ago
Abstract
A non-invasive variable depth ultrasound treatment method and system comprises a variable depth transducer system configured for providing ultrasound treatment to a patient. An exemplary variable depth transducer system can comprise a transducer configured to provide treatment to more than one region of interest, such as between a deep treatment region of interest and a superficial region of interest, and/or a subcutaneous region of interest. The variable depth transducer can comprise a transduction element having a piezoelectrically active layer, matching layers and/or other materials for generating radiation or acoustical energy. The variable depth transducer may be configured to operate at moderate frequencies within the range from approximately 750 kHz to 20 MHz or more. In addition, the transduction element may be configured with a variable depth device comprising one or more materials configured to allow for control and focusing/defocusing of the acoustic energy to more than one region of interest.
Description
FIELD OF INVENTION

This invention generally relates to an ultrasound system, and more particularly, to a method and system for variable depth ultrasound treatment.


BACKGROUND OF THE INVENTION

Many conventional applications of therapeutic ultrasound have employed low frequency transducers. These transducers have operational frequencies that typically range from 500 kHz to 1.5 MHz. Such low frequency transducers are often preferred because they allow for acoustical energy to be focused deep into the body, without harming the overlying tissue structures.


A conventional application of noninvasive therapeutic ultrasound using a low frequency transducer is depicted in FIG. 1. A conventional therapeutic system 100 comprises a transducer 102 that uses low frequency energy to treat a deep treatment region 110. Deep treatment region 110 is located at a deep depth 106 below a superficial region 112, e.g., tissue layers and structures, and a subcutaneous region 114 of a patient. Deep depth 106 may range from several millimeters to 5-7 centimeters or more. Conventional system 100 cannot treat superficial regions 112 or subcutaneous regions 114 through use of low-frequency transducer 102, thus limiting the applications of such systems. For example, some cosmetic surgeries ma also need to provide treatment to superficial and/or subcutaneous, as well as deep treatment regions, thus eliminating the use of lower frequency transducers.


Another undesirable side effect of low-frequency therapy is that the acoustic energy must pass through intervening tissue layers before reaching the desired deep treatment area. The intervening layers tend to defocus the rays and absorb some of the acoustic energy. This causes the focal spot size to widen, making it difficult to control the location of the focal snot.


SUMMARY OF THE INVENTION

In accordance with various aspects of the present invention, a variable depth ultrasound treatment method and system are provided. An exemplary method and system comprise a variable depth transducer system configured for providing ultrasound treatment to more than one region of interest, such as between at least two of a deep treatment region of interest, a superficial region of interest, and/or a subcutaneous region of interest.


In accordance with various exemplary embodiments, a variable depth transducer system can be configured for spatial control, such as by changing the distance from an exemplary transducer to a reflecting surface, or changing the angles of energy focused or unfocused to the region of interest, and/or configured for temporal control, such as by controlling changes in the frequency, drive amplitude and tinting of the exemplary transducer. As a result, changes in the location of the treatment region, the shape and size and/or volume of the spot or region of interest, as well as the thermal conditions, can be dynamically controlled versus time.


In accordance with an exemplary embodiment of the present invention, the variable depth transducer can comprise a transduction element having a piezoelectrically active layer, matching layers and/or other materials for generating radiation or acoustical energy. The variable depth transducer may be configured to operate at moderate frequencies to provide variable depth treatment. For example, an exemplary variable depth transducer system can be configured for providing treatment to a superficial region of interest, and/or to a subcutaneous region of interest utilizing moderate frequencies below 20 MHz, such as within a range from approximately 750 kHz to 20 MHz, or higher frequencies of 35 MHz or more.


In accordance with another exemplary embodiment of the present invention, the transduction element may be configured with a variable depth element comprising one or more materials configured to allow for control and focusing/defocusing of the acoustic energy to more than one region of interest, such as between a deep treatment region of interest and a superficial region of interest, and/or a subcutaneous region of interest. The materials utilized for the variable depth element for control and focusing/defocusing may be configured in a variety of manners and shapes, such as substantially flat, curved, or other arrangements for bending reflecting and/or redirecting radiation and acoustical energy. In addition, the variable depth element may be configured within, or comprise a device coupled to, the transduction element in a variety of manners to provide for focusing/defocusing and control of the treatment energy.


In accordance with another exemplary embodiment of the present invention, an exemplary transducer may be configured to enable energy deposition not only proximate a fundamental frequency of a piezoelectric material within the transduction element, but also at harmonic frequencies of the material, above a fundamental frequency, as well as resonances below a fundamental frequency. These multiple resonances may be controlled and enabled through various focusing techniques and transducer structures, including the adding of matching layers and/or backing layers to shape the resonant characteristics of the transducer.


In accordance with another exemplary embodiment of the present invention, a variable depth acoustic transducer can also be configured for generating high acoustic power for treatment purposes. While also providing for good imaging capabilities. For example, to allow for the treatment spot size to be optimally controlled at various treatment depths, an exemplary embodiment of the present invention may comprise a transducer configured into an array of sub-elements, each sub-element configured for processing acoustic waves with a sufficient bandwidth for good axial resolution.


In accordance with another exemplary embodiment of the present invention, a variable depth transducer may be configured in a probe arrangement to provide treatment. The variable depth transducer may also be configured with various mechanical devices to allow for optimal treatment and therapy, for example to provide controlled positioning of the variable depth transducer, such as through a non-invasive configuration. Further, the variable depth transducer may also be configured for one-dimensional, two-dimensional and annular arrays, and/or for three-dimensional treatment applications.


In accordance with another aspect of the present invention, an exemplary variable depth treatment system and method may also be configured to provide therapeutic heating, cooling and/or imaging of a treatment region as well as acoustically monitoring the temperature profile or other tissue parameter monitoring of the treatment region and the general vicinity thereof. For example, in accordance with an exemplary embodiment, an exemplary variable depth system may be configured with a dynamic feedback arrangement based on monitoring of temperature or other tissue parameters, and/or based on imaging information to suitably adjust the spatial and/or temporal characteristics of the variable depth transducer.





BRIEF DESCRIPTION OF THE DRAWINGS

The subject matter of the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, may best be understood by reference to the following description taken in conjunction with the claims and the accompanying drawing figures, in which like parts may be referred to by like numerals:



FIG. 1 illustrates a diagram of treatment using a prior art ultrasound treatment system:



FIG. 2 illustrates a block diagram of an ultrasound treatment system in accordance with an exemplary embodiment of the present invention;



FIG. 3 illustrates a block diagram of a variable depth ultrasound treatment system in accordance with an exemplary embodiment of the present invention;



FIG. 4 illustrates a diagram of a variable depth ultrasound treatment system in accordance with an exemplary embodiment of the present invention;



FIGS. 5A and 5B illustrate exemplary embodiments for variable depth ultrasound transducers for treatment in accordance with the present invention;



FIG. 6 illustrates another exemplary embodiment for a variable depth ultrasound transducer for treatment in accordance with the present invention;



FIG. 7 illustrates an exemplary embodiment for electronic focusing of a transducer in accordance with the present invention;



FIG. 8 illustrates an exemplary diagram of treatment characteristics of an exemplary transducer operating at the fundamental frequency and other frequencies and/or resonances above and below the fundamental in accordance with the present invention;



FIG. 9 illustrates an exemplary embodiment of a two-dimensional array in accordance with the present invention;



FIG. 10 illustrates an exemplary embodiment of a probe format for treatment in accordance with the present invention;



FIG. 11 illustrates an exemplary embodiment of a mechanism for treatment in accordance with the present invention; and



FIGS. 12A and 12B illustrate an exemplary embodiment of an annular array in accordance with the present invention;





DETAILED DESCRIPTION

The present invention may be described herein in terms of various components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions. For example, the present invention may employ various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the present invention may be practiced in any number of medical or treatment contexts, and the exemplary embodiments relating to a variable depth ultrasound treatment as described herein are merely a few of the exemplary applications for the invention. For example, the principles, features and methods discussed may be applied to any medical or other tissue or treatment application.


In accordance with various aspects of the present invention, a non-invasive variable depth ultrasound treatment method and system are provided. An exemplary method and system comprise a variable depth acoustic transducer system configured for providing ultrasound treatment to more than one region of interest in a patient. For example, with reference to an exemplary embodiment illustrated in a block diagram of FIG. 2, an exemplary system 200 for ultrasound treatment includes a variable depth transducer system 202 that provides treatment to a region of interest 210. Variable depth transducer system 202 may comprise a transducer 204 configured with a variable depth device 206. In providing treatment, variable depth ultrasound system 202 may provide therapy, imaging and/or temperature or other tissue parameter monitoring to region of interest 210. Region of interest 210 can comprise a deep treatment region, a superficial region, and/or a subcutaneous region of interest or any other region of interest located within a patient. To facilitate coupling of variable depth ultrasound system 202 to region of interest 210, variable depth ultrasound system 202 can further comprise a coupling system 208 configured for acoustic coupling of ultrasound energy and signals.


An exemplary variable depth transducer system 300 is further exemplified in a block diagram illustrated in FIG. 3. Variable depth transducer system 300 may comprise a control system 304, a transducer 302, a variable depth element 306, and a coupling system 308. Control system 304 is configured for control and operation of transducer 302 to provide treatment to more than one region of interest. Transducer 302 and variable depth device 306 are configured to provide variable depth ultrasound treatment to a treatment region. Coupling system 303 is configured for coupling of transducer 302 and variable depth device 306 to a region of interest.


Control system 304 may be configured for use within an ultrasound therapy system, an ultrasound imaging system, and/or an ultrasound imaging, therapy and/or treatment monitoring system, including motion control subsystems. In accordance with an exemplary embodiment, a control system 304 may comprise, a processor, a display, and/or one or more input devices. The processor may comprise a personal computer, a Unix system, or any other conventional processing unit. The display may comprise a monitor, LCD screen, or any other device configured to display an image. An input/output device ma comprise a keyboard, a mouse, a touch-screen, or any other device for inputting information. The information from the input device and images displayed may be received or transmitted in any format, such as manually, by analog device, by digital device, and/hr by any other mechanisms. The processor, display, and/of input device may be coupled together in any manner. By coupling, the devices comprising control system 304 may be directly connected to each other or may be connected through one or more other devices or components that allow a signal to travel to/from one component to another. The various coupling components for the devices comprising control system 304 can include but are not limited to the internet, a wireless network, it conventional wire cable, an optical cable or connection through any other medium that conducts signals, and any other coupling device or communication medium.


Coupling system 308 is configured for the coupling ultrasound energy and signals between transducer 302 and variable depth device 306 and a region of interest. Coupling system 308 may facilitate such coupling through use of various coupling mediums, including air and other gases, water and other fluids, gels, solids, and/or any combination thereof, or any other medium that allows for signals to be transmitted between transducer 302/variable depth device 306 and the region of interest. In addition to providing a coupling function, in accordance with an exemplary embodiment, coupling system 308 can also be configured for providing temperature control during the treatment application. For example, coupling system 308 can be configured for controlled cooling of an interface surface or region between transducer 302/variable depth device 306 and the region of interest by suitably controlling the temperature of the coupling medium. The suitable temperature for such coupling medium can be achieved in various manners, and utilize various feedback systems, such as thermocouples, thermistors or any other device or system configured for temperature measurement of a coupling medium. Such controlled cooling can be configured to further facilitate spatial control of variable depth transducer system 300.


Exemplary variable depth transducer 302 can be configured in various manners. For example, a variable depth transducer system can be configured for spatial control, such as by controlled changing of the distance from an exemplary transducer to a reflecting surface or controlled changing of the angles of energy focused or unfocused to the region of interest, e.g., variable depth transducer 302 can be configured with variable depth element 306 comprising a frequency dependent lens configured for control of focal depth and position by changing the frequency of excitation of variable depth transducer 302. In addition, variable depth transducer 302 can also be configured for temporal control, such as by controlling changes in the frequency, drive amplitude and timing of the exemplary transducer. Thus, an exemplary variable depth transducer can be configured with spatial and/or temporal control. As a result, changes in the location of the treatment region, the shape and size and/or volume of the spot or region of interest, as well as the thermal conditions, can be dynamically controlled versus time.


Variable depth element 306 can be suitably coupled to transducer 302 to facilitate variable depth treatment. By coupling, transducer 302 may be directly and/or movably connected to variable depth device 306, or may be connected through one or more various components or elements that enable energy and/or signals to travel to/from one component to another. Transducer 302 and variable depth element 306 may also be combined into a single device, wherein variable depth device 306 is configured within transducer 302 e.g., as a part of as transduction element of transducer 302.


Variable depth element 306 can configured to enable variable depth treatment system 300 to provide treatment to more than one region of interest, such as between a deep treatment region of interest, a superficial region of interest, and/or a subcutaneous region of interest, or other regions in between. Such treatment can occur within a single region of interest, or within more than one region of interest, at the same time. For example, with momentary reference to FIG. 4, an exemplary embodiment of a variable depth treatment system 400 is shown. Variable depth treatment system 400 may be configured for operating within moderate frequencies ranging from approximately 750 kHz to 20 MHz or more. Variable depth treatment system 400 may be configured with a variable depth transducer system 402 comprising a transducer configured, with a variable depth device. Variable depth transducer system 402 may be coupled to a control system for receiving and transmitting signals to/front a region of interest.


During operation, variable depth transducer system 402 may be configured to transmit or receive signals to treat a deep treatment region 410 located at deep depth 406 within a patient. For example, depth 406 for deep treatment region 410 may range from approximately 50 mm to 7 cm or more.


Variable depth transducer system 402 may also be configured to treat a second inner region 422 of a patient. Inner region 422 may comprise a superficial layer 412 of a patient and/or a subcutaneous layer 414 of patient. Inner region 422 is located at a shorter depth 420 within tissue layers of a patient. For example, depth 420 may range from approximately 0 mm to 5 cm or more within a patient, wherein the 0 mm range comprises the outer surface of superficial layer 412 of the patient. In other words, superficial layer 412 of the patient may comprise any area on or near the surface of the patient. Treatment by variable depth treatment system 400 may include treatment of both deep region 410 and inner region 422, or within only one region of interest.


Variable depth element 306 can be configured in various manners to facilitate treatment of more than one region of interest, such as inner region 422 and/or deep-seated region 410. In accordance with an exemplary embodiment of the present invention, transducer 302 may be configured with variable depth element 306 comprising one or more materials configured to allow for control and focusing/defocusing of the acoustic energy to more than one region of interest. For example, with reference to exemplary embodiments illustrated in FIGS. 5A and 5B, a variable depth transducer system 500 can comprise a transducer 502, electrical leads 510, and a variable depth device 528 or 530 suitably configured with transducer 502 to facilitate treatment.


Transducer 502 can include a transduction element comprising a piezoelectrically active material, such as lead zirconante titanate (PZT), or any other piezoelectrically active material, such as a piezoelectric ceramic, crystal, plastic, and/or composite materials, as well as lithium niobate, lead titanate, barium titanate, and/or lead metaniobate. In addition to or instead of a piezoelectrically active material, variable depth transducer 502 may comprise any other materials configured for generating radiation and/or acoustical energy. Variable depth transducer 502 may also comprise one or more matching layers and/or backing layers to suitably shape the resonant character of transducer 502. For example, variable depth transducer 502 may be configured, along with transduction element, with one or more matching layers and/or backing layers coupled to a piezoelectrically active material or any other material configured for generating radiation and/or acoustical energy.


For temporal control, the thickness of the transduction element of variable depth transducer 502 may be selected to provide a center operating frequency of moderate range, for example from approximately 750 kHz to 30 MHz or more. Lower frequencies, e.g., between approximately 750 kHz and 8 MHz, can facilitate deeper penetration and higher frequencies, e.g., between approximately 8 to 20 MHz or more, can facilitate greater resolution. Selecting the frequency for operation can be based on the degree and balance of energy penetration and resolution that is desired for an application.


Electrical leads 510 may be configured to enable power to be transmitted to and signals received from variable depth transducer 502, and can comprise any wiring type, configuration and arrangement for use with ultrasound transducers. Variable depth transducer 502 may also be coupled to electrical leads 510 in various manners. For example, while FIG. 5 depicts electrical leads 510 coupled to only one end of variable depth transducer 502, electrical leads 510 may also be coupled together on an opposite end, or any other location along variable depth transducer 502.


To facilitate spatial control, in an exemplary embodiment, variable depth device 528 can comprise one or more reflective materials 504 configured to provide control and focusing of acoustic or radiation energy from variable depth transducer 502 towards a region of interest 518. In accordance with an exemplary embodiment, reflective materials 504 can comprise acoustic mirrors, lenses, reflectors or prisms configured far focusing of acoustic or radiation energy. The exemplary mirrors, reflectors or prisms may comprise any material for reflecting, bending or redirecting acoustic or radiated energy. For example, such materials may include stainless steel, aluminum, or any other metal, alloy, glass, plastic, or any other material capable of bending, redirecting and/or reflecting back acoustical energy from a surface to another direction.


In accordance with one exemplary embodiment, reflective materials 504 may be suitably inclined at approximately a 45 degree angle with respect to variable depth transducer 502; however, reflective materials 504 may be configured to be inclined at any angle with respect to variable depth transducer 502 such that energy transmitted from variable depth transducer 502 is bent, redirected or reflected from reflective materials 504 towards a region of interest 518. Changing the angle of inclination can suitably control the focusing of acoustic energy to any one region of interest 518, such as to a deep treatment region of interest, a superficial region of interest, or a subcutaneous region of interest.


Variable depth devices 528 and 530 may be configured in a variety of manners, such as substantially flat, curved, or other suitable arrangements for reflecting, bending or redirecting acoustic or radiated energy. For example, with reference to FIG. 5A, variable, depth device 528 can comprise mirrors 504 configured in a substantially flat manner. However, with reference to FIG. 5B, variable depth device 530 can also comprise mirrors 506 configured in a curved arrangement to allow far focusing of energy from variable depth transducer 502 to a region of interest 520. While FIG. 5B illustrates mirrors 506 as substantially spherical and symmetric, mirrors 506 may also be curved in an aspherical and/or asymmetric manner such that energy transmitted from variable depth transducer 502 is bent, redirected, or reflected from mirrors 506 towards a region of interest 520. Still further, mirrors 506 can also be configured in other shapes and arrangements, such as jagged, saw tooth, wavy or other non-planar surfaces, or any other surface or compound surfaces configured for reflecting, bending or redirecting acoustic or radiated energy.


Moreover, while FIG. 5A depicts variable depth device 528 with mirrors 504 configured to be substantially flat, and FIG. 5B depicts variable depth device 530 with mirrors 506 configured to be curved, variable depth devices 528, 530 may also be configured with any combination of substantially flat, curved mirrors, and/or other planar, non-planar or other arrangements for facilitating spatial control. In accordance with an exemplary embodiment utilizing spatial and temporal control, variable depth devices 528 and 530 can be configured with a frequency dependent mirror or lens configured for spatial control of the focal depth and position by changing the frequency of excitation of variable depth transducer 502.


As a result, an exemplary transducer system 500 can be configured for providing treatment to a superficial region of interest and/or to a subcutaneous region of interest utilizing moderate frequencies below approximately 20 MHz. For example, an exemplary transducer system 500 can provide treatment to superficial regions and/or to subcutaneous regions that are more commonly addressed in cosmetic applications with an operating, frequency range from approximately 750 kHz to 35 MHz or more.


Variable depth transducer system 500 can be configured in various arrangements to provide non-invasive treatment. For example, in accordance with an exemplary embodiment, variable depth devices 528, 530 may be configured with variable depth transducer 502 within a housing 536. Housing 536 can comprise any configuration of transducer housing for containing transducers and for interfacing with a patient to allow treatment, such as facilitate noninvasive treatment. Coupling of signals from transducer 502 and variable depth devices 528, 530 through housing 536 to a region of interest may be facilitated through any coupling medium, such as air and other gases, water and other fluids, gels, solids, any combination thereof, and/or any other medium that allows for signals to be transmitted from transducer 502/variable depth devices 528, 530 to a region of interest.


In addition to comprising separate devices and components, variable depth transducer 302 and variable depth element 306 may also comprise the same device, i.e., variable depth element 306 is configured within transducer 302. For example, with reference to an exemplary embodiment illustrated in FIG. 6, a variable depth transducer system 600 can comprise a variable depth transducer 602 configured as a variable depth device to provide for control and focusing of acoustic energy 620 towards a region of interest 630.


Variable depth transducer 602 may comprise a transduction element comprised of a piezoelectrically active material, such as lead zirconante titanate (PZT), or any other piezoelectrically active material, such as a piezoelectric ceramic, crystal, plastic, and/or composite materials, as well as lithium niobate, lead titanate, barium titante, and/or lead metaniobate. Variable depth transducer 602 may also comprise one or more matching and/or backing layers configured along with the piezoelectrically active material. In addition to or instead of a piezoelectrically active material, variable depth transducer 602 may comprise any other materials configured for generating radiation and/or acoustical energy.


In accordance with an exemplary embodiment, variable depth transducer 602 is configured in a curved manner to enable focusing of acoustic energy 620 to region of interest 630. The curvature can be substantially spherical and/or symmetric manner, or curved in an aspherical and/or asymmetric manner. Furthermore, variable depth transducer 602 can comprise any other configuration to enable focusing of acoustic energy 620 to region of interest 630, such as to a deep treatment region of interest, a superficial region of interest, and/or a subcutaneous region of interest. For example, variable depth transducer 602 can be configured in an planar or non-planar arrangement.


For temporal control, the thickness of the transduction element of variable depth transducer 602 may be selected to provide a center operating frequency of moderate range, for example from approximately 750 kHz to 20 MHz. Lower frequencies, e.g., between approximately 750 kHz and 8 MHz, can facilitate deeper penetration and higher frequencies, e.g. between, approximately 8 to 30 MHz or more, facilitate greater resolution. As a result, an exemplary transducer system 600 can be configured for providing treatment to a superficial region of interest and/or to a subcutaneous region of interest utilizing moderate frequencies below 20 MHz. For example, an exemplar transducer system 600 can provide treatment to superficial regions and/or to subcutaneous regions that are more commonly addressed in cosmetic applications with an operating frequency range from approximately 750 kHz to 1.5 MHz or more.


Electrical leads 610 are configured to enable power to be transmitted to and signals received from variable depth transducer 602, and can comprise any wiring type, configuration and arrangement for use with ultrasound transducers. Variable depth transducer 602 may also be coupled to electrical leads 610 in various manners. For example, while FIG. 6 depicts electrical leads 610 coupled to only one side of variable depth transducer 602, electrical leads 610 may also be coupled together on an opposite end, or any other location along variable depth transducer 602.


In addition to having a variable depth transducer 602 configured as a variable depth device to provide for control and focusing of acoustic energy 620 towards a region of interest 630, in accordance with an exemplary embodiment, a variable depth transducer may also be configured electronically to provide for control and focusing of acoustic energy. For example, with reference to an exemplary embodiment depicted in FIG. 7, an exemplary electronic focusing transducer system 700 is illustrated. Electronic focusing transducer system 700 is configured with a variable depth transducer 702. Like transducers 502 and 602, variable depth transducer 702 may comprise a piezoelectrically active material, composite materials, one or more matching layers, and/or any other materials configured for generating, radiation and/or acoustical energy. Variable depth transducer 702 may also comprise a one-dimensional or two dimensional array of transducers.


In accordance with an exemplary embodiment, variable depth transducer 702 comprises one or more transducers and/or transduction elements that can be activated by various drive frequencies with suitable phase delay. For example, variable depth transducer 702 can be activated by a first drive frequency 704, and then subsequently activated by at least one or more delayed drive frequencies 706 or 708. The phase delay in drive frequencies allows for focusing of acoustical energy to occur both tangentially 720 and axially 730.


The drive frequencies 704, 706, 708 transmitted to variable depth transducer 702 may comprise substantially similar frequencies and/or different frequencies, wherein all frequencies are in the moderate range, i.e., between approximately 750 kHz to 20 MHz. The delay between drive frequencies 704, 706, 708 may range from 0 ms to approximately a full period or the drive frequency. For example, the delay may comprise zero or approximately 1/1000th of a drive frequency period up to 15/16.sup.th, 31/32.sup.nd or more of a drive frequency period, with variations comprising any fraction of a full wavelength in time delay.


Electronic phase delay focusing of variable depth transducer 702 may be done tangentially and/or axially. For example, drive frequencies 704, 706, 708 and/or the phase associated with drive frequencies 704, 706, 708 may be varied to provide focusing tangentially and/or axially. In accordance with an exemplary embodiment, variable depth transducer 702 may comprise subapertures that may be turned on and off to also provide focusing tangentially and/or axially. Phased focusing may prevent over-treatment of a region of interest by automating the focus and treatment times for a treatment region. Thus, for example, electronic control of variable depth transducer 702 may be facilitated by shunting various subapertures together to control the effective acoustic size of the source/receiver.


Thus, an exemplary transducer system can comprise a variable depth transducer 502, 602, 702 or any other transducer configuration for providing control and focus of acoustical and radiation energy to more than one region of interest within a patient. Such an exemplary transducer system can comprise a transducer configured with or coupled to a variable depth device or feature to provide energy to more than one region of interest. Moreover, an exemplary transducer system can provide treatment to superficial regions and/or to subcutaneous regions that are more commonly addressed in cosmetic applications with an operating frequency range below 30 MHz, or more, even from approximately 750 kHz to 8 MHz that is not attainable by prior art low-frequency transducers.


In accordance with another aspect of the present invention, a variable depth acoustic transducer can also be configured for generating high acoustic power for treatment purposes, while also providing for good imaging capabilities. To allow for the treatment spot size to be optimally controlled at various treatment depths, an exemplary embodiment of the present invention may comprise a transducer configured into an array of sub-elements.


For example, in accordance with an exemplary embodiment with reference again to FIG. 6, variable depth transducer 602 can comprise a plurality of sub-transduction elements, wherein any of the plurality of sub-transduction elements may be configured to provide for focusing energy 620, e.g., any of the plurality of sub-transduction elements can be configured for processing acoustic waves with a sufficient bandwidth for good axial resolution. The sub-transduction elements may be configured such that all are curved, e.g., with the same or varying curvatures, or with one or more sub-transduction elements being substantially flat, with the remaining sub-transduction elements being curved. Further, the sub-transduction elements can be configured in any other shapes configured to provide for control and focusing of acoustic energy 620 towards a region of interest 630.


In accordance with another exemplary embodiment of the present invention, an exemplary variable depth transducer system 300 may be configured to enable energy deposition not only proximate a fundamental frequency of a piezoelectric material within the transduction element, but also at other frequencies, such as harmonic frequencies of the material, above a fundamental frequency, as well as resonances below a fundamental frequency. These harmonic and below fundamental resonances may be controlled and enabled through various focusing techniques and transducer structures, including the adding of matching layers and/or backing layers to shape the resonant characteristics of the transducer.


For example, energy can be suitably provided to a treatment region at a frequency near the peak acoustic output or peak acoustic transmit efficiency of transducer 302 when a piezoelectrically active material is driven near its fundamental frequency. Different sized and shaped piezoelectric materials have different fundamental frequencies for various electrode configurations. In accordance with an exemplary embodiment, energy can also be deposited when the piezoelectric material is driven above its fundamental frequency, e.g., at harmonics, or when driven below the fundamental frequency. The use of the multiple frequency characteristics of transducer 302 may be controlled and enabled through various transducer configurations, acoustic control and/or focusing techniques.


In accordance with an exemplary embodiment, the multiple frequencies may be enabled through the concentration of acoustic energy through the variable depth device 306. Enablement of the multiple frequencies allows for treatment at various depths corresponding to the different frequencies. For example, with additional reference to the acoustic output versus frequency curve illustrated in FIG. 8, variable depth transducer system 300 may treat multiple regions, represented by curve 800. Driving moderate frequencies through transducer 302 and variable depth device 306 may enable treatment of a first deep region 804, treatment of a second shallower region 808, and treatment of a third inner region 812. With respect to treatment techniques, various therapy, imaging and/or temperature monitoring applications may be provided to regions 804, 808, and/or 812. While three treatment regions are depicted in FIG. 8, variable depth transducer system 300 may be configured to enable multiple frequencies for treatment of two, four, or more regions.


In accordance with another aspect of the invention, the variable depth transducer 302 may be configured to provide one, two or three-dimensional treatment applications for focusing acoustic energy to one or more regions of interest. For example, as discussed above, variable depth transducer 302 can be suitably diced to form a one-dimensional array, e.g., transducer 602 comprising a single array of sub-transduction elements.


In accordance with another exemplary embodiment, variable depth transducer 302 may be suitably diced in two-dimensions to form a two-dimensional array. For example, with reference to FIG. 9, an exemplary two-dimensional array 900 can be suitably diced into a plurality of two-dimensional portions 902. Two-dimensional portions 902 can be suitably configured to focus on the treatment region at a certain depth, and thus provide respective slices 904 of the treatment region. As a result, the two-dimensional array 900 can provide a two-dimensional slicing of the image place of a treatment region, thus providing two-dimensional treatment.


In accordance with another exemplary embodiment, variable depth transducer 302 may be suitably configured to provide three-dimensional treatment. For example, to provide-three dimensional treatment of a region of interest, with reference again to FIG. 3, a three-dimensional system can comprise variable depth transducer 302 configured with an adaptive algorithm, such as, for example, one utilizing three-dimensional graphic software, contained in a control system, such as control system 304. The adaptive algorithm is suitably configured to receive two-dimensional imaging, temperature and/or treatment information relating to the region of interest, process the received information, and then provide corresponding three-dimensional imaging, temperature and/or treatment information.


In accordance with an exemplary embodiment, with reference again to FIG. 9, an exemplary three-dimensional system can comprise a two-dimensional array 900 configured with an adaptive algorithm to suitably receive 904 slices from different image planes of the treatment region, process the received information, and then provide volumetric information 906, e.g., three-dimensional imaging, temperature and/or treatment information. Moreover, after processing the received information with the adaptive algorithm, the two-dimensional array 900 may suitably provide therapeutic heating to the volumetric region 906 as desired.


Alternatively, rather than utilizing an adaptive algorithm, such as three-dimensional software, to provide three-dimensional imaging and/or temperature information, an exemplary three-dimensional system can comprise a single variable depth transducer 302 configured within a probe arrangement to operate from various rotational and/or translational positions relative to a target region.


For example, with reference to FIG. 10, a probe 1010 can be configured to rotate around a perimeter of a treatment region 1014 to provide three-dimensional imaging and temperature information. Probe 1010 may comprise a variable depth transducer system, such as, for example with reference to FIG. 3, variable depth transducer 302 configured with variable depth device 306. In the exemplary embodiment, probe 1010 may be coupled to control system 304 through connector 1012. Connector 1012 may compose a wire, optical cable, wireless connection, or any other device capable of sending and/or receiving information from control system 304 to variable depth transducer 302 and variable depth device 306 housed within probe 100.


Probe 1010 may be configured to rotate around an axis 1016 to provide three-dimensional information. The rotational movement can comprise movement in either a clockwise or counterclockwise direction, or both. Further, the rotational movement could include complete or partial rotations. Thus, the rotational movement could include movement between only two positions, or between any other number of rotational positions. Still further, probe 1010 can be configured to translate or sweep along axis 1016 to provide a larger field-of-view and this facilitate additional three-dimensional information. Accordingly, the probe system 1000 may comprise rotational and/or translational movement suitably configured to provide three-dimensional information.


Rotational and/or translational movement of probe 1010 may be controlled by maximally placing probe 100 in various desired rotational positions around the treatment region 1014. The movement of variable depth transducer 302 within probe 1010 in various rotational and/or translational positions can also be controlled by any mechanical scanning device now known or hereinafter devised for automated movement. For example, with reference to an exemplary embodiment illustrated in FIG. 11, automated rotational and/or translational movement may be achieved through use of a robotic arm mechanism 1100. Robotic arm mechanism 1100 comprises a manually and/or electromechanically actuated robotic arm 1112 coupled with a probe 1110 and a control 1114.


Probe 1110 may comprise a variable depth transducer system, such as variable depth transducer 302 configured with variable depth device 306. Movement of probe 1110 is mechanically provided through the operation of robotic arm 1112. Robotic arm 1112 may comprise one or more sub-segments that allow precise movement and precise measurement of position in one or more up to any direction. Robotic arm 1112 may be driven by control system 1114. Control system 1114 may comprise a drive box, gears or any other device for providing mechanical movement of robotic arm 1112. Control system 1114 may also comprise a processor, a display, and/or an input/output device. Probe 1110 may be further coupled to control system 1114 through a wire or optical cable configured alongside or within robotic arm 1112, a wireless connection, or any other device capable of sending and/or receiving information from control system 1114 to variable depth transducer 302 and variable depth device 306 housed within niche 1110.


Control system 1114 may provide movement and control of robotic arm 1112 with up to six degrees of freedom. Control system 1114 rosy allow fin movement of robotic arm 1112 to be referenced with one or more fixed positions in space. Control system 1114 may also allow for movement of robotic arm 1112 to be referenced with one or more fixed positions on a patient.


While the three-dimensional systems may include a single acoustic transducer configured with a two-dimensional array 900 and an adaptive algorithm to provide three-dimensional imaging, temperature monitoring and therapeutic heating to a treatment region; the three-dimensional system may also be configured to include both an adaptive algorithm and rotational and/or translational movement to provide additional information. As such, an even larger area of treatment may be obtained through the use of both the adaptive algorithm and the rotational and/or translational movement.


Continuing with this example, the three-dimensional system can be suitably configured to capture imaging and temperature information and provide therapeutic heating from variable depth transducer 302 once variable depth transducer 302 becomes fixedly maintained at various rotational positions. The three-dimensional system can also be suitably configured to capture imaging and temperature information and provide therapeutic heating just prior to, or just after, becoming fixedly positioned. The three-dimensional system can also be configured to capture imaging and temperature information and provide therapy during movement around the various rotational positions.


In addition to one, two or three-dimensional arrays, an exemplary variable depth transducer can also be configured within an annular array to provide planar, focused and/or defocused acoustical energy to more than one region of interest. For example, in accordance with an exemplary embodiment, with reference to FIGS. 12A and 12B, an annular array 1200 comprising a plurality of rings 1202, 1204, 1206 to N. Rings 1202, 1204, 1206 to N can be mechanically and electrically isolated into a set of individual elements, and can create planar, focused, or defocused waves. For example, such waves can be centered on-axis, such as by methods of adjusting corresponding transmit anther receive delays τ1, τ2, τ3, . . . τn. An electronic focus can be suitably moved along various depth positions, and can enable variable strength or beam tightness, while an electronic defocus can have varying amounts of defocusing. In accordance with an exemplary embodiment, a lens can also be provided to aid focusing or defocusing such that any time differential delays can be reduced. Movement of annular array 1200 in one, two or three-dimensions, or along any path, such as through use of probe 1000 and/or robotic arm mechanism 1100, may be implemented to scan and/or treat a volume or any corresponding space within a region of interest.


In accordance with another exemplary embodiment of the present invention, exemplary variable depth treatment system and method may also be configured to provide therapeutic heating, cooling and/or imaging of a treatment region as well as acoustically monitoring the temperature profile or other tissue parameter monitoring of the treatment region and the general vicinity thereof. In accordance with an exemplary embodiment, an exemplary variable depth system may be configured with a dynamic feedback arrangement based on monitoring of temperature or other tissue parameters, and/or based on imaging information to suitably adjust the spatial and/or temporal characteristics of the variable depth transducer. Such imaging and other temperature or tissue parameter information can be suitably collected from ultrasound signals transmitted from an exemplary variable depth transducer, or from separate devices configured for collecting such information, e.g., a laser device configured with a receiver for profiling temperature, imaging or other such information.


For example, with reference again to FIG. 4, such feedback information can be utilized to dynamically adjust the height, e.g., with a standoff, or distance of a transduction element within variable depth transducer system 402 from superficial layer 412. Such adjustment of the distance and/or location of variable depth transducer system 402 can be controlled either manually of mechanically. Changing the distance of variable depth transducer system 402 can result in a change in the depth of penetration of the acoustical energy within a region of interest, for example, from an inner region 422 to a deep region 410. The depth of penetration of the acoustical energy can also be suitably changed by changing the temperature of any couplant configured between variable depth transducer system 402 from superficial layer 412, and/or the temperature of any coolant.


Feedback information may be suitably generated or provided by any one or more acoustical sources, such as B-scan images, A-lines, Doppler or color flow images, surface acoustic wave devices, hydrophones, elasticity measurement, or shear wave based devices. In addition, optical sources can also be utilized, such as video and/or infrared cameras, laser Doppler imagers, optical coherence tomography hungers, and temperature sensors. Further, feedback information can also be suitably provided by semiconductors, such as thermistors or solid state temperature sensors, by electronic and electromagnetic sensors, such as impedance and capacitance measurement devices and/or thermocouples, and by mechanical sensors, such as stiffness gages, strain gages or stress measurement sensors, or any suitably combination thereof. Moreover, various other switches, acoustic or other sensing mechanisms and methods may be suitably employed to enable transducer 402 to be acoustically coupled to one or more regions of interest.


The present invention has been described above with reference to various exemplary embodiments. However those skilled in the art will recognize that changes and modifications may be made to the exemplary embodiments without departing from the scope of the present invention. For example, the various operational steps, as well as the components for carrying out the operational steps, may be implemented in alternate ways depending upon the particular application or in consideration of any number of cost functions associated with the operation of the system, e.g. various of the steps may be deleted, modified, or combined with other steps. Further, it should be noted that while the method and system for ultrasound treatment with a variable depth transducer as described above is suitable for use by a medical practitioner proximate the patient, the system can also be accessed remotely, i.e., the medical practitioner can view through a remote display having imaging information transmitted in various manners of communication, such as by satellite/wireless or by wired connections such as IP or digital cable networks and the like, and can direct a local practitioner as to the suitable placement for the transducer. Moreover, while the various exemplary embodiments may comprise non-invasive configurations, an exemplary variable depth transducer system can also be configured for at least some level of invasive treatment application. These and other changes or modifications are intended to be included within the scope of the present invention, as set forth in the following claims.

Claims
  • 1. A non-invasive ultrasound treatment system for providing treatment to a patient, the system comprising: a variable depth transducer system comprising: a transducer having a surface and comprising at least one transduction element, and a variable depth element comprising a reflective surface, wherein:the variable depth transducer system operable to provide treatment to a region of interest between a superficial and subcutaneous region of a patient, andthe reflective surface is configured to be inclined at any angle with respect to the transducer such that energy emitted by the surface of the transducer is bent, redirected or reflected from the reflective surface towards the region of interest;wherein the variable depth transducer comprises a spatial control operable to change the angle of inclination of the reflective surface to focus the energy emitted by the surface of the transducer to any depth in the region of interest; anda controller in communication with the transducer and the variable depth element, the controller comprising a control of the spatial control and a control of a frequency of the energy.
  • 2. A non-invasive ultrasound treatment system for providing treatment to a patient, the system comprising: a variable depth transducer system comprising: a transducer having a surface and comprising at least one transduction element; anda variable depth element comprising a reflective surface and a spatial control, the reflective surface configured to be inclined at an angle with respect to the transducer such that energy emitted by the surface of the transducer is bent, redirected or reflected from the reflective surface towards the region of interest, the spatial control configured to adjust the angle; anda controller in communication with the transducer and the variable depth element, the controller configured to direct the spatial control to change the angle of inclination of the reflective surface to direct the energy emitted from the surface of the transducer to a pre-determined depth in the region of interest and to adjust a frequency of the energy.
  • 3. The non-invasive ultrasound treatment system according to claim 2, wherein the variable depth transducer is configured for variable control of the energy to change a depth location for a lesion created with the region of interest.
  • 4. The non-invasive ultrasound treatment system according to claim 2 further comprising a coupling system configured for acoustic coupling between the variable depth transducer system and the region of interest.
  • 5. The non-invasive ultrasound treatment system according to claim 4 wherein the coupling system is configured fix temperature control of the transducer to facilitate adjustment of a focal depth of the energy emitted by the surface of the transducer.
  • 6. The non-invasive ultrasound treatment system according to claim 2, further comprising a mechanical scanning device configured to move the variable depth transducer system in at least one of a translational movement and a rotational movement.
  • 7. The non-invasive ultrasound treatment system according to claim 2 wherein the variable depth transducer system is configured to image the region of interest.
  • 8. The non-invasive ultrasound treatment system according to claim 2, wherein the frequency of the energy is in a range of 750 kHz to 20 MHz.
  • 9. The non-invasive ultrasound treatment system according to claim 2, wherein the frequency of the energy is in a range of 750 kHz to 8 MHz or a range of 8 MHz to 20 MHz.
  • 10. The non-invasive ultrasound treatment system according to claim 2, wherein the transducer is coupled to the variable depth element and is configured to focus the energy emitted by the surface of the transducer to any depth in more than one region of interest.
  • 11. The non-invasive ultrasound treatment system according to claim 2, wherein the reflective surface comprises at least one mirror.
  • 12. The non-invasive ultrasound treatment system according to claim 11, wherein the mirror is substantially flat in shape.
  • 13. The non-invasive ultrasound treatment system according to claim 11, wherein the mirror is curved in shape.
  • 14. The non-invasive ultrasound treatment system according to claim 2, wherein the transducer is configured with spatial control to change at least one of a distance from the transducer to the reflective surface, and an angle of the energy delivered into the region of interest.
  • 15. The non-invasive ultrasound treatment system according to claim 2, wherein the transducer is configured in a curved manner.
  • 16. The non-invasive ultrasound treatment system according to claim 2, wherein the at least one transduction element is a plurality of transduction elements configured to be activated by a plurality of frequencies separated by at least one phase delay.
  • 17. The non-invasive ultrasound treatment system according to claim 2, wherein the controller further comprises a display unit for displaying at least one of imaging information, positional information and temperature information of a treatment region.
  • 18. The non-invasive ultrasound treatment system according to claim 2, wherein the controller further comprises a robotic arm arrangement for controlling movement of the variable depth.
  • 19. The non-invasive ultrasound treatment system according to claim 18, wherein the controller movement of the variable depth transducer system is configured to create a plurality of lesions at varying depths in the region of interest.
  • 20. The non-invasive ultrasound treatment system according to claim 2, wherein the energy is focused to a first depth in the superficial region and the energy is focused to a second depth in the subcutaneous region, wherein the first depth and the second depth is in a range from 0 mm to 5 cm, and the first depth is less than the second depth.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/834,754 entitled “SYSTEM AND METHOD FOR VARIABLE DEPTH ULTRASOUND TREATMENT” filed on Jul. 12, 2010, issued as U.S. Pat. No. 8,708,915 on Apr. 29, 2014, which is a continuation of U.S. patent application Ser. No. 10/944,500 entitled “SYSTEM AND METHOD FOR VARIABLE DEPTH ULTRASOUND TREATMENT” filed on Sep. 16, 2004, issued as U.S. Pat. No. 7,824,348 on Nov. 2, 2010, all of which are incorporated herein by reference.

US Referenced Citations (826)
Number Name Date Kind
2427348 Bond et al. Sep 1947 A
3913386 Saglio Oct 1975 A
3965455 Hurwitz Jun 1976 A
3992925 Perilhou Nov 1976 A
4039312 Patru Aug 1977 A
4059098 Murdock Nov 1977 A
4101795 Fukumoto Jul 1978 A
4166967 Benes et al. Sep 1979 A
4211948 Brisken et al. Jul 1980 A
4211949 Brisken et al. Jul 1980 A
4213344 Rose Jul 1980 A
4276491 Daniel Jun 1981 A
4315514 Drewes et al. Feb 1982 A
4325381 Glenn Apr 1982 A
4343301 Indech Aug 1982 A
4372296 Fahim Feb 1983 A
4379145 Masuho et al. Apr 1983 A
4381007 Doss Apr 1983 A
4381787 Hottinger May 1983 A
4397314 Vaguine Aug 1983 A
4409839 Tanezer Oct 1983 A
4431008 Wanner et al. Feb 1984 A
4441486 Pounds Apr 1984 A
4452084 Taenzer Jun 1984 A
4484569 Driller et al. Nov 1984 A
4507582 Glenn Mar 1985 A
4513749 Kino Apr 1985 A
4513750 Heyman et al. Apr 1985 A
4527550 Ruggers et al. Jul 1985 A
4528979 Marchenko Jul 1985 A
4534221 Fife et al. Aug 1985 A
4566459 Umemura et al. Jan 1986 A
4567895 Putzke Feb 1986 A
4586512 Do-Huu May 1986 A
4601296 Yerushalmi Jul 1986 A
4620546 Aida et al. Nov 1986 A
4637256 Sugiyama et al. Jan 1987 A
4646756 Watmough et al. Mar 1987 A
4663358 Hyon May 1987 A
4668516 Duraffourd et al. May 1987 A
4672591 Breimesser et al. Jun 1987 A
4680499 Umemura et al. Jul 1987 A
4697588 Reichenberger Oct 1987 A
4754760 Fukukita et al. Jul 1988 A
4757820 Itoh Jul 1988 A
4771205 Mequio Sep 1988 A
4801459 Liburdy Jan 1989 A
4803625 Fu et al. Feb 1989 A
4807633 Fry Feb 1989 A
4817615 Fukukita et al. Apr 1989 A
4858613 Fry et al. Aug 1989 A
4860732 Hasegawa et al. Aug 1989 A
4865041 Hassler Sep 1989 A
4865042 Umemura Sep 1989 A
4867169 Machida Sep 1989 A
4874562 Hyon Oct 1989 A
4875487 Seppi Oct 1989 A
4891043 Zeimer et al. Jan 1990 A
4893624 Lele Jan 1990 A
4896673 Rose Jan 1990 A
4900540 Ryan et al. Feb 1990 A
4901729 Saitoh et al. Feb 1990 A
4917096 Englehart Apr 1990 A
4973096 Jaworski Apr 1990 A
4932414 Coleman et al. Jun 1990 A
4938216 Lele Jul 1990 A
4938217 Lele Jul 1990 A
4947046 Kawabata et al. Aug 1990 A
4951653 Fry et al. Aug 1990 A
4955365 Fry et al. Sep 1990 A
4958626 Nambu Sep 1990 A
4976709 Sand Dec 1990 A
4979501 Valchanov Dec 1990 A
4992989 Watanabe et al. Feb 1991 A
5012797 Liang May 1991 A
5018508 Fry et al. May 1991 A
5030874 Saito et al. Jul 1991 A
5036855 Fry et al. Aug 1991 A
5040537 Katakura Aug 1991 A
5054310 Flynn Oct 1991 A
5054470 Fry et al. Oct 1991 A
5070879 Herres Dec 1991 A
5088495 Miyagawa Feb 1992 A
5115814 Griffith May 1992 A
5117832 Sanghvi et al. Jun 1992 A
5123418 Saurel Jun 1992 A
5143063 Feltner Sep 1992 A
5143074 Dory Sep 1992 A
5149319 Unger Sep 1992 A
5150711 Dory Sep 1992 A
5150714 Green Sep 1992 A
5152294 Mochizuki et al. Oct 1992 A
5156144 Iwasaki Oct 1992 A
5158536 Sekins Oct 1992 A
5159931 Pini Nov 1992 A
5163421 Bernstein Nov 1992 A
5163436 Saitoh et al. Nov 1992 A
5178135 Uchiyama et al. Jan 1993 A
5190518 Takasu Mar 1993 A
5190766 Ishihara Mar 1993 A
5191880 McLeod Mar 1993 A
5205287 Erbel et al. Apr 1993 A
5209720 Unger May 1993 A
5212671 Fujii et al. May 1993 A
5215680 Arrigo Jun 1993 A
5224467 Oku Jul 1993 A
5230334 Klopotek Jul 1993 A
5230338 Allen et al. Jul 1993 A
5247924 Suzuki et al. Sep 1993 A
5255681 Ishimura et al. Oct 1993 A
5257970 Dougherty Nov 1993 A
5265614 Hayakawa Nov 1993 A
5267985 Shimada et al. Dec 1993 A
5269297 Weng Dec 1993 A
5282797 Chess Feb 1994 A
5295484 Marcus et al. Mar 1994 A
5295486 Wollschlaeger et al. Mar 1994 A
5304169 Sand Apr 1994 A
5305756 Entrekin et al. Apr 1994 A
5321520 Inga et al. Jun 1994 A
5323779 Hardy et al. Jun 1994 A
5327895 Hashimoto et al. Jul 1994 A
5348016 Unger et al. Sep 1994 A
5360268 Hayashi Nov 1994 A
5370121 Reichenberger et al. Dec 1994 A
5371483 Bhardwaj Dec 1994 A
5375602 Lancee et al. Dec 1994 A
5379773 Hornsby Jan 1995 A
5380280 Peterson Jan 1995 A
5380519 Schneider et al. Jan 1995 A
5383917 Desai et al. Jan 1995 A
5391140 Schaetzle et al. Feb 1995 A
5391197 Burdette et al. Feb 1995 A
5392259 Bolorforosh Feb 1995 A
5396143 Seyed-Bolorforosh et al. Mar 1995 A
5398689 Connor et al. Mar 1995 A
5406503 Williams, Jr. et al. Apr 1995 A
5417216 Tanaka May 1995 A
5419327 Rohwedder May 1995 A
5423220 Finsterwald et al. Jun 1995 A
5435311 Umemura et al. Jul 1995 A
5438998 Hanafy Aug 1995 A
5458596 Lax Oct 1995 A
5460179 Okunuki et al. Oct 1995 A
5460595 Hall et al. Oct 1995 A
5469854 Unger et al. Nov 1995 A
5471488 Fujio Dec 1995 A
5487388 Rello et al. Jan 1996 A
5492126 Hennige et al. Feb 1996 A
5496256 Bock Mar 1996 A
5501655 Rolt et al. Mar 1996 A
5503152 Oakley et al. Apr 1996 A
5503320 Webster et al. Apr 1996 A
5507790 Weiss Apr 1996 A
5520188 Hennige May 1996 A
5522869 Burdette et al. Jun 1996 A
5523058 Umemura Jun 1996 A
5524620 Rosenschein Jun 1996 A
5524624 Tepper Jun 1996 A
5524625 Okazaki et al. Jun 1996 A
5526624 Berg Jun 1996 A
5526812 Dumoulin et al. Jun 1996 A
5526814 Cline et al. Jun 1996 A
5526815 Granz et al. Jun 1996 A
5529070 Augustine et al. Jun 1996 A
5540235 Wilson Jul 1996 A
5558092 Unger et al. Sep 1996 A
5560362 Sliwa et al. Oct 1996 A
5575291 Hayakawa Nov 1996 A
5575807 Faller Nov 1996 A
5577502 Darrow et al. Nov 1996 A
5577507 Snyder et al. Nov 1996 A
5577991 Akui et al. Nov 1996 A
5580575 Unger et al. Dec 1996 A
5601526 Chapelon et al. Feb 1997 A
5603323 Pflugrath et al. Feb 1997 A
5609562 Kaali Mar 1997 A
5615091 Palatnik Mar 1997 A
5617858 Taverna et al. Apr 1997 A
5618275 Bock Apr 1997 A
5620479 Diederich Apr 1997 A
5622175 Sudol et al. Apr 1997 A
5638819 Manwaring et al. Jun 1997 A
5643179 Fujimoto Jul 1997 A
5644085 Lorraine et al. Jul 1997 A
5647373 Paltieli Jul 1997 A
5655535 Friemel et al. Aug 1997 A
5655538 Lorraine Aug 1997 A
5657760 Ying et al. Aug 1997 A
5658328 Johnson Aug 1997 A
5660836 Knowlton Aug 1997 A
5662116 Kondo et al. Sep 1997 A
5665053 Jacobs Sep 1997 A
5665141 Vago Sep 1997 A
5671746 Dreschel et al. Sep 1997 A
5673699 Trahey et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5685820 Riek et al. Nov 1997 A
5687737 Branham et al. Nov 1997 A
5690608 Watanabe Nov 1997 A
5694936 Fujimoto et al. Dec 1997 A
5697897 Buchholtz et al. Dec 1997 A
5701900 Shehada et al. Dec 1997 A
5704361 Seward et al. Jan 1998 A
5706252 Le Verrier et al. Jan 1998 A
5706564 Rhyne Jan 1998 A
5715823 Wood et al. Feb 1998 A
5720287 Chapelon et al. Feb 1998 A
5722411 Suzuki et al. Mar 1998 A
5727554 Kalend et al. Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5743863 Chapelon Apr 1998 A
5746005 Steinberg May 1998 A
5746762 Bass May 1998 A
5748767 Raab May 1998 A
5749364 Sliwa et al. May 1998 A
5755228 Wilson et al. May 1998 A
5755753 Knowlton May 1998 A
5762066 Law et al. Jun 1998 A
5763886 Schulte Jun 1998 A
5769790 Watkins et al. Jun 1998 A
5779644 Eberle et al. Jul 1998 A
5792058 Lee et al. Aug 1998 A
5795297 Daigle Aug 1998 A
5795311 Wess Aug 1998 A
5810009 Mine et al. Sep 1998 A
5810888 Fenn Sep 1998 A
5814599 Mitragotri et al. Sep 1998 A
5817013 Ginn et al. Oct 1998 A
5817021 Reichenberger Oct 1998 A
5820564 Slayton Oct 1998 A
5823962 Schaetzle et al. Oct 1998 A
5827204 Grandia et al. Oct 1998 A
5839751 Bonin Nov 1998 A
5840032 Hatfield et al. Nov 1998 A
5844140 Seale Dec 1998 A
5853367 Chalek et al. Dec 1998 A
5869751 Bonin Feb 1999 A
5871524 Knowlton Feb 1999 A
5873902 Sanghvi et al. Feb 1999 A
5876431 Spehr et al. Mar 1999 A
5879303 Averkiou et al. Mar 1999 A
5882557 Hayakawa Mar 1999 A
5891034 Bucholz Apr 1999 A
5899861 Friemel et al. May 1999 A
5904659 Duarte May 1999 A
5919219 Knowlton Jul 1999 A
5923099 Bilir Jul 1999 A
5924989 Polz Jul 1999 A
5928169 Schaetzle et al. Jul 1999 A
5931805 Brisken Aug 1999 A
5938606 Bonnefous Aug 1999 A
5938612 Kline-Schoder Aug 1999 A
5948011 Knowlton Sep 1999 A
5957844 Dekel Sep 1999 A
5957882 Nita et al. Sep 1999 A
5957941 Ream Sep 1999 A
5967980 Ferre et al. Oct 1999 A
5968034 Fulmer Oct 1999 A
5971949 Levin Oct 1999 A
5977538 Unger et al. Nov 1999 A
5984882 Rosenschein et al. Nov 1999 A
5990598 Sudol et al. Nov 1999 A
5992236 White Nov 1999 A
5997471 Gumb et al. Dec 1999 A
5997497 Nita et al. Dec 1999 A
5999843 Anbar Dec 1999 A
6004262 Putz et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6013032 Savord Jan 2000 A
6016255 Bolan et al. Jan 2000 A
6019724 Gronningsaeter et al. Feb 2000 A
6022308 Williams Feb 2000 A
6022327 Chang Feb 2000 A
6036646 Barthe Mar 2000 A
6039048 Silberg Mar 2000 A
6039689 Lizzi Mar 2000 A
6042556 Beach Mar 2000 A
6049159 Barthe Apr 2000 A
6050943 Slayton et al. Apr 2000 A
6059727 Fowlkes May 2000 A
6071239 Cribbs et al. Jun 2000 A
6080108 Dunham Jun 2000 A
6083148 Williams Jul 2000 A
6086535 Ishibashi et al. Jul 2000 A
6086580 Mordon et al. Jul 2000 A
6090054 Tagishi Jul 2000 A
6093883 Sanghvi Jul 2000 A
6101407 Groezinger Aug 2000 A
6106469 Suzuki et al. Aug 2000 A
6113558 Rosenschein et al. Sep 2000 A
6113559 Klopotek Sep 2000 A
6120452 Barthe Sep 2000 A
6123081 Durette Sep 2000 A
6126619 Peterson et al. Oct 2000 A
6135971 Hutchinson et al. Oct 2000 A
6139499 Wilk Oct 2000 A
6159150 Yale et al. Dec 2000 A
6171244 Finger et al. Jan 2001 B1
6176840 Nishimura Jan 2001 B1
6183426 Akisada Feb 2001 B1
6183502 Takeuchi Feb 2001 B1
6183773 Anderson Feb 2001 B1
6190323 Digs Feb 2001 B1
6190336 Duarte Feb 2001 B1
6193658 Wendelken et al. Feb 2001 B1
6210327 Brackett et al. Apr 2001 B1
6213948 Barthe Apr 2001 B1
6216029 Paltieli Apr 2001 B1
6233476 Strommer et al. May 2001 B1
6234990 Rowe et al. May 2001 B1
6241753 Knowlton Jun 2001 B1
6246898 Vesely et al. Jun 2001 B1
6251074 Averkiou Jun 2001 B1
6251088 Kaufman et al. Jun 2001 B1
6268405 Yao Jul 2001 B1
6273864 Duarte Aug 2001 B1
6280402 Ishibashi et al. Aug 2001 B1
6287257 Matichuk Sep 2001 B1
6296619 Brisken Oct 2001 B1
6301989 Brown et al. Oct 2001 B1
6309355 Cain et al. Oct 2001 B1
6311090 Knowlton Oct 2001 B1
6315741 Martin Nov 2001 B1
6322509 Pan et al. Nov 2001 B1
6322532 D'Sa Nov 2001 B1
6325540 Lounsberry et al. Dec 2001 B1
6325758 Carol et al. Dec 2001 B1
6325769 Klopotek Dec 2001 B1
6325798 Edwards et al. Dec 2001 B1
6338716 Hossack et al. Jan 2002 B1
6350276 Knowlton Feb 2002 B1
6356780 Licato et al. Mar 2002 B1
6361531 Hissong Mar 2002 B1
6370411 Osadchy et al. Apr 2002 B1
6375672 Aksan Apr 2002 B1
6377854 Knowlton Apr 2002 B1
6377855 Knowlton Apr 2002 B1
6381497 Knowlton Apr 2002 B1
6381498 Knowlton Apr 2002 B1
6387380 Knowlton May 2002 B1
6390982 Bova et al. May 2002 B1
6405090 Knowlton Jun 2002 B1
6409720 Hissong Jun 2002 B1
6413216 Cain et al. Jul 2002 B1
6413253 Koop Jul 2002 B1
6413254 Hissong Jul 2002 B1
6419648 Vitek Jul 2002 B1
6423007 Lizzi et al. Jul 2002 B2
6425865 Salcudean Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6425912 Knowlton Jul 2002 B1
6428477 Mason Aug 2002 B1
6428532 Doukas Aug 2002 B1
6430446 Knowlton Aug 2002 B1
6432057 Mazess et al. Aug 2002 B1
6432067 Martin et al. Aug 2002 B1
6432101 Weber Aug 2002 B1
6436061 Costantino Aug 2002 B1
6438424 Knowlton Aug 2002 B1
6440071 Slayton Aug 2002 B1
6440121 Weber Aug 2002 B1
6443914 Constantino Sep 2002 B1
6453202 Knowlton Sep 2002 B1
6461378 Knowlton Oct 2002 B1
6470216 Knowlton Oct 2002 B1
6488626 Lizzi et al. Dec 2002 B1
6491657 Rowe Dec 2002 B2
6500121 Slayton Dec 2002 B1
6500141 Ilion Dec 2002 B1
6508774 Acker et al. Jan 2003 B1
6511427 Sliwa, Jr. et al. Jan 2003 B1
6511428 Azuma Jan 2003 B1
6514244 Pope Feb 2003 B2
6517484 Wilk et al. Feb 2003 B1
6524250 Weber Feb 2003 B1
6666835 Martin Mar 2003 B2
6540679 Slayton Apr 2003 B2
6540685 Rhoads et al. Apr 2003 B1
6540700 Fujimoto et al. Apr 2003 B1
6554771 Buil et al. Apr 2003 B1
6569099 Babaev May 2003 B1
6569108 Sarvazyan et al. May 2003 B2
6572552 Fukukita Jun 2003 B2
6575956 Brisken et al. Jun 2003 B1
6595934 Hissong Jul 2003 B1
6599256 Acker Jul 2003 B1
6607498 Eshel Aug 2003 B2
6618620 Freundlich et al. Sep 2003 B1
6623430 Slayton Sep 2003 B1
6626854 Friedman Sep 2003 B2
6626855 Weng et al. Sep 2003 B1
6638226 He et al. Oct 2003 B2
6645162 Friedman Nov 2003 B2
6662054 Kreindel Dec 2003 B2
6663627 Francischelli Dec 2003 B2
6665806 Shimizu Dec 2003 B1
6669638 Miller et al. Dec 2003 B1
6685640 Fry Feb 2004 B1
6692450 Coleman Feb 2004 B1
6699237 Weber Mar 2004 B2
6716184 Vaezy et al. Apr 2004 B2
6719449 Laughlin Apr 2004 B1
6719694 Weng et al. Apr 2004 B2
6726627 Lizzi et al. Apr 2004 B1
6825176 Mourad Apr 2004 B2
6733449 Krishnamurthy et al. May 2004 B1
6749624 Knowlton Jun 2004 B2
6773409 Truckai et al. Aug 2004 B2
6775404 Pagoulatos et al. Aug 2004 B1
6790187 Thompson et al. Sep 2004 B2
6824516 Batten et al. Nov 2004 B2
6835940 Morikawa et al. Dec 2004 B2
6846290 Lizzi et al. Jan 2005 B2
6875176 Mourad et al. Apr 2005 B2
6882884 Mosk et al. Apr 2005 B1
6887239 Elstrom et al. May 2005 B2
6889089 Behl May 2005 B2
6896657 Willis May 2005 B2
6902536 Manna et al. Jun 2005 B2
6905466 Salgo Jun 2005 B2
6918907 Kelly Jul 2005 B2
6920883 Bessette Jul 2005 B2
6921371 Wilson Jul 2005 B2
6932771 Whitmore Aug 2005 B2
6932814 Wood Aug 2005 B2
6936044 McDaniel Aug 2005 B2
6936046 Hissong Aug 2005 B2
6945937 Culp et al. Sep 2005 B2
6948843 Laugharn et al. Sep 2005 B2
6953941 Nakano et al. Oct 2005 B2
6958043 Hissong Oct 2005 B2
6971994 Young et al. Dec 2005 B1
6974417 Lockwood et al. Dec 2005 B2
6976492 Ingle Dec 2005 B2
6992305 Maezawa et al. Jan 2006 B2
6997923 Anderson Feb 2006 B2
7006874 Knowlton Feb 2006 B2
7020528 Neev Mar 2006 B2
7022089 Ooba Apr 2006 B2
7058440 Heuscher et al. Jun 2006 B2
7063666 Weng Jun 2006 B2
7070565 Vaezy et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7094252 Koop Aug 2006 B2
7108663 Talish et al. Sep 2006 B2
7115123 Knowlton Oct 2006 B2
7122029 Koop et al. Oct 2006 B2
7142905 Slayton Nov 2006 B2
7165451 Brooks et al. Jan 2007 B1
7179238 Hissong Feb 2007 B2
7189230 Knowlton Mar 2007 B2
7229411 Slayton Jun 2007 B2
7235592 Muratoglu Jun 2007 B2
7258674 Cribbs Aug 2007 B2
7273459 Desilets Sep 2007 B2
7294125 Phalen et al. Nov 2007 B2
7297117 Trucco Nov 2007 B2
7303555 Makin et al. Dec 2007 B2
7327071 Nishiyama et al. Feb 2008 B2
7331951 Eshel et al. Feb 2008 B2
7332985 Larson, III et al. Feb 2008 B2
7347855 Eshel Mar 2008 B2
RE40403 Cho et al. Jun 2008 E
7393325 Barthe Jul 2008 B2
7398116 Edwards Jul 2008 B2
7399279 Abend et al. Jul 2008 B2
7491171 Barthe et al. Feb 2009 B2
7510536 Foley et al. Mar 2009 B2
7530356 Slayton May 2009 B2
7530958 Slayton May 2009 B2
7571336 Barthe Aug 2009 B2
7601120 Moilanen et al. Oct 2009 B2
7615015 Coleman Nov 2009 B2
7615016 Barthe Nov 2009 B2
7686763 Vaezy et al. Mar 2010 B2
7695437 Quistgaard et al. Apr 2010 B2
7758524 Barthe Jul 2010 B2
7789841 Huckle et al. Sep 2010 B2
7824348 Barthe Nov 2010 B2
7846096 Mast et al. Dec 2010 B2
7857773 Desilets et al. Dec 2010 B2
7875023 Eshel et al. Jan 2011 B2
7914453 Slayton et al. Mar 2011 B2
7914469 Torbati Mar 2011 B2
7931611 Novak et al. Apr 2011 B2
7955281 Pedersen et al. Jun 2011 B2
7967764 Lidgren et al. Jun 2011 B2
7967839 Flock et al. Jun 2011 B2
8057389 Barthe et al. Nov 2011 B2
8057465 Sliwa, Jr. et al. Nov 2011 B2
8066641 Barthe et al. Nov 2011 B2
8123707 Huckle et al. Feb 2012 B2
8128618 Gliklich et al. Mar 2012 B2
8133180 Slayton et al. Mar 2012 B2
8133191 Rosenberg et al. Mar 2012 B2
8166332 Barthe et al. Apr 2012 B2
8197409 Foley et al. Jun 2012 B2
8206299 Foley et al. Jun 2012 B2
8211017 Foley et al. Jul 2012 B2
8262591 Pedersen et al. Sep 2012 B2
8273037 Kreindel et al. Sep 2012 B2
8282554 Makin et al. Oct 2012 B2
8333700 Barthe et al. Dec 2012 B1
8366622 Slayton et al. Feb 2013 B2
8409097 Slayton et al. Apr 2013 B2
8444562 Barthe et al. May 2013 B2
8480585 Slayton et al. Jul 2013 B2
8506486 Slayton et al. Aug 2013 B2
8523775 Barthe et al. Sep 2013 B2
8535228 Slayton et al. Sep 2013 B2
8585618 Hunziker et al. Nov 2013 B2
8636665 Slayton et al. Jan 2014 B2
8641622 Barthe et al. Feb 2014 B2
8663112 Slayton et al. Mar 2014 B2
8672848 Slayton et al. Mar 2014 B2
8690778 Slayton et al. Apr 2014 B2
8690779 Slayton et al. Apr 2014 B2
8690780 Slayton et al. Apr 2014 B2
8708935 Barthe et al. Apr 2014 B2
8715186 Slayton et al. May 2014 B2
8726781 Eckhoff et al. May 2014 B2
20010009997 Pope Jul 2001 A1
20010009999 Kaufman et al. Jul 2001 A1
20010014780 Martin et al. Aug 2001 A1
20010014819 Ingle et al. Aug 2001 A1
20010031922 Weng et al. Oct 2001 A1
20010039380 Larson et al. Nov 2001 A1
20010041880 Brisken Nov 2001 A1
20020000763 Jones Jan 2002 A1
20020002345 Marlinghaus Jan 2002 A1
20020040199 Klopotek Apr 2002 A1
20020040442 Ishidera Apr 2002 A1
20020052550 Madsen et al. May 2002 A1
20020055702 Atala May 2002 A1
20020062077 Emmenegger et al. May 2002 A1
20020062142 Knowlton May 2002 A1
20020072691 Thompson et al. Jun 2002 A1
20020082528 Friedman et al. Jun 2002 A1
20020082529 Suorsa et al. Jun 2002 A1
20020082589 Friedman et al. Jun 2002 A1
20020087080 Slayton et al. Jul 2002 A1
20020095143 Key Jul 2002 A1
20020099094 Anderson Jul 2002 A1
20020115917 Honda et al. Aug 2002 A1
20020128648 Weber Sep 2002 A1
20020143252 Dunne et al. Oct 2002 A1
20020156400 Babaev Oct 2002 A1
20020161357 Anderson Oct 2002 A1
20020165529 Danek Nov 2002 A1
20020168049 Schriever Nov 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020169442 Neev Nov 2002 A1
20020173721 Grunwald et al. Nov 2002 A1
20020193784 Mchale et al. Dec 2002 A1
20020193831 Smith Dec 2002 A1
20030009153 Brisken et al. Jan 2003 A1
20030014039 Barzell et al. Jan 2003 A1
20030018255 Martin Jan 2003 A1
20030028111 Vaezy et al. Feb 2003 A1
20030028113 Gilbert et al. Feb 2003 A1
20030032900 Ella Feb 2003 A1
20030036706 Slayton Feb 2003 A1
20030040739 Koop Feb 2003 A1
20030060736 Martin et al. Feb 2003 A1
20030050678 Sierra Mar 2003 A1
20030055417 Truckai et al. Mar 2003 A1
20030040442 Ishidera Apr 2003 A1
20030065313 Koop Apr 2003 A1
20030074023 Kaplan Apr 2003 A1
20030083536 Eshel May 2003 A1
20030092988 Makin May 2003 A1
20030097071 Halmann et al. May 2003 A1
20030099383 Lefebvre May 2003 A1
20030125629 Ustuner Jul 2003 A1
20030139790 Ingle et al. Jul 2003 A1
20030171678 Batten et al. Sep 2003 A1
20030171701 Babaev Sep 2003 A1
20030176790 Slayton Sep 2003 A1
20030191396 Sanghvi Oct 2003 A1
20030200481 Stanley Oct 2003 A1
20030212129 Liu et al. Nov 2003 A1
20030212351 Hissong Nov 2003 A1
20030212393 Knowlton Nov 2003 A1
20030216795 Harth Nov 2003 A1
20030220536 Hissong Nov 2003 A1
20030220585 Hissong Nov 2003 A1
20030229331 Brisken et al. Dec 2003 A1
20030233085 Giammarusti Dec 2003 A1
20030236487 Knowlton Dec 2003 A1
20040000316 Knowlton Jan 2004 A1
20040001809 Brisken Jan 2004 A1
20040002705 Knowlton Jan 2004 A1
20040010222 Nunomura et al. Jan 2004 A1
20040015106 Coleman Jan 2004 A1
20040030227 Littrup Feb 2004 A1
20040039312 Hillstead Feb 2004 A1
20040039418 Elstrom Feb 2004 A1
20040041563 Lewin et al. Mar 2004 A1
20040041880 Ikeda et al. Mar 2004 A1
20040042168 Yang et al. Mar 2004 A1
20040044375 Diederich et al. Mar 2004 A1
20040049134 Tosaya et al. Mar 2004 A1
20040049734 Simske Mar 2004 A1
20040059266 Fry Mar 2004 A1
20040068186 Ishida et al. Apr 2004 A1
20040073079 Altshuler et al. Apr 2004 A1
20040073113 Salgo Apr 2004 A1
20040073115 Horzewski et al. Apr 2004 A1
20040073116 Smith Apr 2004 A1
20040073204 Ryan et al. Apr 2004 A1
20040077977 Ella et al. Apr 2004 A1
20040082857 Schonenberger et al. Apr 2004 A1
20040082859 Schaer Apr 2004 A1
20040102697 Evron May 2004 A1
20040105559 Aylward et al. Jun 2004 A1
20040122323 Vortman et al. Jun 2004 A1
20040122493 Ishbashi et al. Jun 2004 A1
20040143297 Ramsey Jul 2004 A1
20040152982 Hwang et al. Aug 2004 A1
20040158150 Rabiner et al. Aug 2004 A1
20040186535 Knowlton Sep 2004 A1
20040189155 Funakubo Sep 2004 A1
20040206365 Knowlton Oct 2004 A1
20040210214 Knowlton Oct 2004 A1
20040217675 Desilets Nov 2004 A1
20040249318 Tanaka Dec 2004 A1
20040254620 Lacoste et al. Dec 2004 A1
20040267252 Washington et al. Dec 2004 A1
20050033201 Takahashi Feb 2005 A1
20050033316 Kertz Feb 2005 A1
20050038340 Vaezy et al. Feb 2005 A1
20050055073 Weber Mar 2005 A1
20050061834 Garcia et al. Mar 2005 A1
20050070961 Maki Mar 2005 A1
20050074407 Smith Apr 2005 A1
20050080469 Larson Apr 2005 A1
20050091770 Mourad et al. May 2005 A1
20050096542 Weng et al. May 2005 A1
20050104690 Larson, III et al. May 2005 A1
20050113689 Gritzky May 2005 A1
20050134314 Prather et al. Jun 2005 A1
20050137656 Malak Jun 2005 A1
20050143677 Young et al. Jun 2005 A1
20050154313 Desilets Jul 2005 A1
20050154314 Quistgaard Jul 2005 A1
20050154332 Zanelli Jul 2005 A1
20050154431 Quistgaard Jul 2005 A1
20050187495 Quistgaard Aug 2005 A1
20050191252 Mitsui Sep 2005 A1
20050193451 Quistgaard et al. Sep 2005 A1
20050197681 Barolet et al. Sep 2005 A1
20050228281 Nefos Oct 2005 A1
20050240170 Zhang et al. Oct 2005 A1
20050251120 Anderson et al. Nov 2005 A1
20050256406 Barthe Nov 2005 A1
20050261584 Eshel Nov 2005 A1
20050261585 Makin et al. Nov 2005 A1
20050267454 Hissong Dec 2005 A1
20050288748 Li et al. Dec 2005 A1
20060004306 Altshuler Jan 2006 A1
20060020260 Dover et al. Jan 2006 A1
20060025756 Francischelli Feb 2006 A1
20060042201 Curry Mar 2006 A1
20060058664 Barthe Mar 2006 A1
20060058671 Vitek et al. Mar 2006 A1
20060058707 Barthe Mar 2006 A1
20060058712 Altshuler et al. Mar 2006 A1
20060074309 Bonnefous Apr 2006 A1
20060074313 Slayton et al. Apr 2006 A1
20060074314 Slayton Apr 2006 A1
20060074355 Slayton Apr 2006 A1
20060079816 Barthe Apr 2006 A1
20060079868 Makin Apr 2006 A1
20060084891 Barthe Apr 2006 A1
20060089632 Barthe Apr 2006 A1
20060089688 Panescu Apr 2006 A1
20060094988 Tosaya et al. May 2006 A1
20060111744 Makin May 2006 A1
20060116583 Ogasawara et al. Jun 2006 A1
20060116671 Slayton Jun 2006 A1
20060122508 Slayton Jun 2006 A1
20060122509 Desilets Jun 2006 A1
20060161062 Arditi et al. Jul 2006 A1
20060184069 Vaitekunas Aug 2006 A1
20060184071 Klopotek Aug 2006 A1
20060189972 Grossman Aug 2006 A1
20060206105 Chopra Sep 2006 A1
20060229514 Wiener Oct 2006 A1
20060241440 Eshel Oct 2006 A1
20060241442 Barthe Oct 2006 A1
20060241470 Novak et al. Oct 2006 A1
20060250046 Koizumi et al. Nov 2006 A1
20060261584 Eshel Nov 2006 A1
20060282691 Barthe Dec 2006 A1
20060291710 Wang et al. Dec 2006 A1
20070032784 Gliklich et al. Feb 2007 A1
20070035201 Desilets Feb 2007 A1
20070055154 Torbati Mar 2007 A1
20070055155 Owen et al. Mar 2007 A1
20070055156 Desilets Mar 2007 A1
20070065420 Johnson Mar 2007 A1
20070083120 Cain et al. Apr 2007 A1
20070087060 Dietrich Apr 2007 A1
20070088245 Babaev et al. Apr 2007 A1
20070088346 Mirizzi et al. Apr 2007 A1
20070161902 Dan Jul 2007 A1
20070166357 Shaffer et al. Jul 2007 A1
20070167709 Slayton Jul 2007 A1
20070208253 Slayton Sep 2007 A1
20070219604 Yaroslaysky et al. Sep 2007 A1
20070219605 Yaroslaysky et al. Sep 2007 A1
20070238994 Stecco et al. Oct 2007 A1
20070239075 Rosenberg et al. Oct 2007 A1
20070239079 Manstein et al. Oct 2007 A1
20070239142 Altshuler et al. Oct 2007 A1
20080027328 Klopotek et al. Jan 2008 A1
20080039724 Seip et al. Feb 2008 A1
20080071255 Barthe Mar 2008 A1
20080086054 Slayton Apr 2008 A1
20080097253 Pederson Apr 2008 A1
20080139974 Da Silva Jun 2008 A1
20080146970 Litman et al. Jun 2008 A1
20080167556 Thompson et al. Jul 2008 A1
20080183077 Moreau-Gobard et al. Jul 2008 A1
20080188745 Chen et al. Aug 2008 A1
20080195000 Spooner et al. Aug 2008 A1
20080200810 Buchalter Aug 2008 A1
20080200813 Quistgaard Aug 2008 A1
20080214966 Slayton Sep 2008 A1
20080221491 Slayton Sep 2008 A1
20080223379 Stuker et al. Sep 2008 A1
20080243035 Crunkilton Oct 2008 A1
20080269608 Anderson et al. Oct 2008 A1
20080275342 Barthe Nov 2008 A1
20080281206 Bartlett et al. Nov 2008 A1
20080281236 Eshel et al. Nov 2008 A1
20080281237 Slayton Nov 2008 A1
20080281255 Slayton Nov 2008 A1
20080294073 Barthe et al. Nov 2008 A1
20080319356 Cain et al. Dec 2008 A1
20090005680 Jones et al. Jan 2009 A1
20090012394 Hobelsberger et al. Jan 2009 A1
20090043198 Milner et al. Feb 2009 A1
20090043293 Pankratov et al. Feb 2009 A1
20090069677 Chen et al. Mar 2009 A1
20090093737 Chomas et al. Apr 2009 A1
20090156969 Santangelo Jun 2009 A1
20090171252 Bockenstedt et al. Jul 2009 A1
20090177122 Peterson Jul 2009 A1
20090177123 Peterson Jul 2009 A1
20090182231 Barthe et al. Jul 2009 A1
20090216159 Slayton et al. Aug 2009 A1
20090226424 Hsu Sep 2009 A1
20090227910 Pedersen et al. Sep 2009 A1
20090253988 Slayton et al. Oct 2009 A1
20090299175 Bernstein et al. Dec 2009 A1
20090318909 Debenedictis et al. Dec 2009 A1
20100011236 Barthe et al. Jan 2010 A1
20100022919 Peterson Jan 2010 A1
20100022922 Barthe et al. Jan 2010 A1
20100042020 Ben-Ezra Feb 2010 A1
20100049178 Deem et al. Feb 2010 A1
20100063422 Hynynen et al. Mar 2010 A1
20100130891 Taggart et al. May 2010 A1
20100160782 Slayton et al. Jun 2010 A1
20100160837 Hunziker et al. Jun 2010 A1
20100168576 Poland et al. Jul 2010 A1
20100191120 Kraus et al. Jul 2010 A1
20100241035 Barthe et al. Sep 2010 A1
20100280420 Barthe et al. Nov 2010 A1
20100286518 Lee et al. Nov 2010 A1
20110040171 Foley et al. Feb 2011 A1
20110040190 Jahnke et al. Feb 2011 A1
20110087099 Eshel et al. Apr 2011 A1
20110087255 Mccormack et al. Apr 2011 A1
20110112405 Barthe et al. May 2011 A1
20110178444 Slayton et al. Jul 2011 A1
20110190745 Uebelhoer et al. Aug 2011 A1
20110264012 Lautzenhiser et al. Oct 2011 A1
20120004549 Barthe et al. Jan 2012 A1
20120016239 Barthe et al. Jan 2012 A1
20120029353 Slayton et al. Feb 2012 A1
20120035475 Barthe et al. Feb 2012 A1
20120035476 Barthe et al. Feb 2012 A1
20120046547 Barthe et al. Feb 2012 A1
20120053458 Barthe et al. Mar 2012 A1
20120111339 Barthe et al. May 2012 A1
20120143056 Slayton et al. Jun 2012 A1
20120165668 Slayton et al. Jun 2012 A1
20120165848 Slayton et al. Jun 2012 A1
20120197120 Makin et al. Aug 2012 A1
20120197121 Slayton et al. Aug 2012 A1
20120215105 Slayton et al. Aug 2012 A1
20120271294 Barthe et al. Oct 2012 A1
20120296240 Azhari et al. Nov 2012 A1
20120316426 Foley et al. Dec 2012 A1
20120330197 Makin et al. Dec 2012 A1
20120330222 Barthe et al. Dec 2012 A1
20120330223 Makin et al. Dec 2012 A1
20130012755 Slayton Jan 2013 A1
20130012816 Slayton et al. Jan 2013 A1
20130012838 Jaeger et al. Jan 2013 A1
20130012842 Barthe Jan 2013 A1
20130018286 Slayton et al. Jan 2013 A1
20130046209 Slayton et al. Feb 2013 A1
20130066208 Barthe et al. Mar 2013 A1
20130066237 Smotrich et al. Mar 2013 A1
20130072826 Slayton et al. Mar 2013 A1
20130096471 Slayton et al. Apr 2013 A1
20130190659 Slayton et al. Jul 2013 A1
20130211258 Barthe et al. Aug 2013 A1
20130281853 Slayton et al. Oct 2013 A1
20130281891 Slayton et al. Oct 2013 A1
20130296697 Slayton et al. Nov 2013 A1
20130296700 Slayton et al. Nov 2013 A1
20130303904 Barthe et al. Nov 2013 A1
20130303905 Barthe et al. Nov 2013 A1
20130310863 Barthe et al. Nov 2013 A1
20140082907 Barthe Mar 2014 A1
20140142430 Slayton et al. May 2014 A1
20140148834 Barthe et al. May 2014 A1
20140180174 Slayton et al. Jun 2014 A1
20140187944 Slayton et al. Jul 2014 A1
20140188015 Slayton et al. Jul 2014 A1
20140188145 Slayton et al. Jul 2014 A1
Foreign Referenced Citations (94)
Number Date Country
4029175 Mar 1992 DE
10140064 Mar 2003 DE
10219217 Nov 2003 DE
10219297 Nov 2003 DE
20314479 Mar 2004 DE
0344773 Dec 1989 EP
1479412 Nov 1991 EP
0473553 Mar 1992 EP
0661029 Jul 1995 EP
1050322 Nov 2000 EP
1234566 Aug 2002 EP
1262160 Dec 2002 EP
1374944 Jan 2004 EP
2113099 Aug 1983 GB
63036171 Feb 1988 JP
03048299 Mar 1991 JP
3123559 May 1991 JP
03136642 Jun 1991 JP
4089058 Mar 1992 JP
04150847 May 1992 JP
7080087 Mar 1995 JP
07505793 Jun 1995 JP
7222782 Aug 1995 JP
09047458 Feb 1997 JP
11505440 May 1999 JP
11506636 Jun 1999 JP
2000166940 Jun 2000 JP
2001170068 Jun 2001 JP
2002078764 Mar 2002 JP
2002515786 May 2002 JP
2002521118 Jul 2002 JP
2002537939 Nov 2002 JP
2003050298 Feb 2003 JP
2003204982 Jul 2003 JP
2004147719 May 2004 JP
2005503388 Feb 2005 JP
2005527336 Sep 2005 JP
2005323213 Nov 2005 JP
2006520247 Sep 2006 JP
2007505793 Mar 2007 JP
2009518126 May 2009 JP
2010517695 May 2010 JP
1020010024871 Mar 2001 KR
100400870 Oct 2003 KR
1020060113930 Nov 2006 KR
1020070065332 Jun 2007 KR
1020070070161 Jul 2007 KR
1020070098856 Oct 2007 KR
1020070104878 Oct 2007 KR
1020070114105 Nov 2007 KR
9625888 Aug 1996 WO
9639079 Dec 1996 WO
9735518 Oct 1997 WO
9832379 Jul 1998 WO
9933520 Jul 1999 WO
9949788 Oct 1999 WO
0006032 Feb 2000 WO
0015300 Mar 2000 WO
0021612 Apr 2000 WO
0053113 Sep 2000 WO
0128623 Apr 2001 WO
0182777 Nov 2001 WO
0182778 Nov 2001 WO
0187161 Nov 2001 WO
0209813 Feb 2002 WO
02024050 Mar 2002 WO
02092168 Nov 2002 WO
020292168 Nov 2002 WO
03053266 Jul 2003 WO
03065347 Aug 2003 WO
03070105 Aug 2003 WO
03077833 Aug 2003 WO
03086215 Oct 2003 WO
03096883 Nov 2003 WO
03099177 Dec 2003 WO
03101530 Dec 2003 WO
2004000116 Dec 2003 WO
2004080147 Sep 2004 WO
2004110558 Dec 2004 WO
2005011804 Feb 2005 WO
2005065408 Jul 2005 WO
2005090978 Sep 2005 WO
2006036870 Apr 2006 WO
2006042163 Apr 2006 WO
2006042168 Apr 2006 WO
2006042201 Apr 2006 WO
2006065671 Jun 2006 WO
2006082573 Aug 2006 WO
2007067563 Jun 2007 WO
2008024923 Feb 2008 WO
2008036622 Mar 2008 WO
2009013729 Jan 2009 WO
2009149390 Dec 2009 WO
2014055708 Apr 2014 WO
Non-Patent Literature Citations (71)
Entry
PCT International Search Report and Written Opinion, PCT/US2014/030779, dated Sep. 1, 2014, 8 pages.
European Patent Office, Examination Report, EP 07814933.3, dated Aug. 5, 2014, 5 pages.
European Patent Office, Examination Report, EP 05798870.1, dated Oct. 20, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185100.4, dated Oct. 24, 2014, 4 pages.
European Patent Office, Examination Report, EP 10185112.9, dated Oct. 24, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185117.8, dated Oct. 24, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185120.2, dated Oct. 24, 2014, 4 pages.
Sanghvi, N.T., et al., “Transrectal Ablation of Prostrate Tissue Using Focused Ultrasound,” 1993 Ultrasonics Symposium, IEEE, pp. 1207-1210.
Sassen, Sander, “ATI's R520 architecture, the new king of the hill?” http://www.hardwareanalysis.com/content/article/1813, Sep. 16, 2005, 2 pages.
Seip, Ralf, et al., “Noninvasive Detection of Thermal Effects Due to Highly Focused Ultrasonic Fiels,” IEEE Symposium, pp. 1229-1232, vol. 2, Oct. 3-Nov. 1993.
Seip, Ralf, et al., “Noninvasive Estimation of Tissue Temperature Response to Heating Fields Using Diagnostic Ultrasound,” IEEE Transactions on Biomedical Engineering, vol. 42, No. 8, Aug. 1995, pp. 828-839.
Simon et al., “Applications of Lipid-Coated Microbubble Ultrasonic Contrast to Tumor Therapy,” Ultrasound in Med. & Biol. vol. 19, No. 2, pp. 123-125 (1993).
Smith, Nadine Barrie, et al., “Non-Invasive In Vivo Temperature Mapping of Ultrasound Heating Using Magnetic Resonance Techniques”, 1994 Ultrasonics Symposium, pp. 1829-1832, vol. 3.
Surry et al., “Poly(vinyl alcohol) cryogel phantoms for use in ultrasound and MR imaging,” Phys. Med. Biol., Dec. 6, 2004, pp. 5529-5546, vol. 49.
Syka J. E. P. et al., “Peptide and Protein Sequence Analysis by Electron Transfer Dissociation Mass Spectometry,” Proceedings of the National Academy of Sciences of USA, National Academy of Aceince, Washington, DC, vol. 101, No. 26, Jun. 29, 2004, pp. 9528-9533.
Talbert, D. G., “An Add-On Modification for Linear Array Real-Time Ultrasound Scanners to Produce 3D Displays,” UTS Int'l 1977 Brighton, England (Jun. 28-30, 1977) pp. 57-67.
Tata et al., “Interaction of Ultrasound and Model Membrane Systems: Analyses and Predictions,” American Chemical Society, Phys. Chem. 1992, 96, pp. 3548-3555.
Ueno, S., et al., “Ultrasound Thermometry in Hyperthermia”, 1990 Ultrasonic Symposium, pp. 1645-1652.
Wang, H., et al., “Limits on Focused Ultrasound for Deep Hyperthermia”, 1994 Ultrasonic Symposium, Nov. 1-4, 1994, pp. 1869-1872, vol. 3.
Wasson, Scott, “NVIDIA's GeFroce 7800 GT graphics processor Power MADD,” http://techreport.com/reviews/2005q2/geforce-7800gtx/index.x?pg=1, Jun. 22, 2005, 4 pages.
White et al “Selective Creation of Thermal Injury Zones in the Superficial Musculoaponeurotic System Using Intense Ultrasound Therapy,” Arch Facial Plastic Surgery, Jan./Feb. 2007, vol. 9, No. 1.
Alster, Tinas S., Tanzi, Elizabeth L., “Cellulite Treatment using a Novel Combination Radiofrequency, Infrared Light, and Mechanical Tissue Manipulation Device,” Journal of Cosmetic & Laser Therapy, Jun. 2005, vol. 7, Issue 2, pp. 81-85.
Arthur et al., “Non-invasive estimation of hyperthermia temperatures with ultrasound,” Int. J. Hyperthermia, Sep. 2005, 21(6), pp. 589-600.
Barthe et al., “Ultrasound therapy system and ablation results utilizing miniature imaging/therapy arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1792-1795, vol. 3.
Calderhead et al., One Mechanism Behind LED Photo-Therapy for Wound Healing and Skin Rejuvenation: Key Role of the Mast Cell, Laser Therapy, Jul. 2008, pp. 141-148, 17.3.
Chen, L. et al., ““Effect of Blood Perfusion on the ablation of liver perenchyma with high intensity focused ultrasound,”” Phys. Med. Biol; 38:1661-1673; 1993b.
Coon, Joshua et al., “Protein identification using sequential ion/ion reactions and tandem mass spectometry” Proceedings of the National Academy of Sciences of the USA, vol. 102, No. 27, Jul. 5, 2005, pp. 9463-9468.
European Examination Report in related Application No. 05808908.7 dated Jun. 29, 2009.
European Examination Report in related Application No. 05810308.6 dated Jun. 29, 2009.
European Examination Report in related Application No. 09835856.7 dated Apr. 11, 2004.
European Examination Report in related Application No. 10185100.4 dated Jan. 6, 2014.
European Examination Report in related Application No. 10185120.2 dated Jan. 22, 2014.
Corry, Peter M., et al., “Human Cancer Treatment with Ultrasound”, IEEE Transactions on Sonics and Ultrasonics, vol. SU-31, No. 5, Sep. 1984, pp. 444,456.
Damianou et al., Application of the Thermal Dose Concept for Predicting the Necrosed Tissue Volume During Ultrasound Surgery,“” 1993 IEEE Ultrasound Symposium, pp. 1199-1202.
Daum et al., “Design and Evaluation of a Feedback Based Phased Array System for Ultrasound Surgery,” IEEE Transactions on Ultrasonics, Feroelectronics, and Frequency Control, vol. 45, No. 2, Mar. 1998, pp. 431-438.
Davis, Brian J., et al., “An Acoustic Phase Shift Technique for the Non-Invasive Measurement of Temperature Changes in Tissues”, 1985 Ultrasonics Symposium, pp. 921-924.
Decision of the Korean Intellectual Property Tribunal dated Jun. 28, 2013 regarding Korean Patent No. 10-1142108, wich is related to the pending application and/or application identified in the Table on the pages 2-5 of the information Disclosure Statement herein (English translation, English translation certification, and Korean decision included).
Fry, W.J. et al., “Production of Focal Destructive Lesions in the Central Nervous System with Ultrasound,” J. Neurosurg., 11:471-478; 1954.
Gliklich et al., Clinical Pilot Study of Intense Ultrasound therapy to Deep Dermal Facial Skin and Subcutaneous Tissues, Arch Facial Plastic Surgery, Mar. 1, 2007, vol. 9.
Harr, G.R. et al., “Tissue Destruction with Focused Ultrasound in Vivo,” Eur. Urol. 23 (suppl. 1):8-11; 1993.
Hassan et al., “Structure and Applications of Poly(vinyl alcohol) Hydrogels Produced by Conventional Crosslinking or by Freezing/Thawing Methods,” advanced in Polymer Science, 2000, pp. 37-65, vol. 153.
Hassan et al., “Structure and Morphology of Freeze/Thawed PVA Hydrogels,” Macromolecules, Mar. 11, 2000, pp. 2472-2479, vol. 33, No. 7.
Husseini et al, “The Role of Cavitation in Acoustically Activated Drug Delivery,” J. Control Release, Oct. 3, 2005, pp. 253-261, vol. 107(2).
Husseini et al. “Investigating the mechanism of accoustically activated uptake of drugs from Pluronic micelles,” BMD Cancer 2002, 2:20k, Aug. 30, 2002, pp. 1-6.
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046122.
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046123.
International Search Report and Written Opinion dated Jan. 28, 2012 in Application No. PCT/US2012/046327.
International Search Report and Written Opinion dated Jan. 28, 2013 in Application No. PCT/US2012/046125.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001361.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001362.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001366.
International Search Report and Written Opinion dated Apr. 6, 2012 in Application No. PCT/US2011/001366.
International Search Report and Written Opinion dated Apr. 6, 2012 in Application No. PCT/US2011/001367.
Jeffers et al., “Evaluation of the Effect of Cavitation Activity on Drug-Ultrasound Synergisms,” 1993 IEEE. Ultrasonics Symposium, pp. 925-928.
Jeffers et al., “Evaluation of the Effect of Cavitation Activity on Drug-Ultrasound Synergisms,” 1993 IEEE Ultrasonics Symposium, pp. 925-928.
Jenne, J., et al., “Temperature Mapping for High Energy US-Therapy”, 1994 Ultrasonics Symposium, pp. 1879-1882.
Johnson, S.A., et al., “Non-Intrusive Measurement of Microwave and Ultrasound-Induced Hyperthermia by Acoustic temperature Tomography”, Ultrasonics Symposium Proceedings, pp. 977-982.
Madersbacher, S. et al., “Tissue Ablation in Bening Prostatic Hyperlasia with High Intensity Focused Ultrasound,” Dur. Urol., 23, (suppl. 1):39-43;1993.
Makin et al, “B-Scan Imaging and Thermal Lesion Monitoring Using Miniaturized Dual-Functionality Ultrasound Arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1788-1791, vol. 3.
Makin et al, “Miniaturized Ultrasound Arrays for Interstitial Ablation and Imaging,” UltraSound Med. Biol. 2005, Nov. 1, 2005, pp. 1539-1550, vol. 31(11).
Makin et al., “Confirmal Bulk Ablation and Therapy Monitoring Using Intracorporeal Image-Treat Ultrasound Arrays”, 4th International Symposium on Therapeutic Ultrasound, Sep. 19, 2004.
Manohar et al, “Photoaccoustic mammography laboratory prototype: imaging of breast tissue phantoms,” Journal of Biomedical Optics, Nov./Dec. 2004, pp. 1172-1181, vol. 9, No. 6.
Mast et al, “Bulk Ablation of Soft Tissue with Intense Ultrasound; Modeling nad Experiments,” J. Acoust. Soc. Am., Oct. 1, 2005, pp. 2715-2724, vol. 118(4).
Mitragotri, Samir; “Healing sound: the use of ultrasound in drug delivery and other therapeutic applications,” Nature Reviews; Drug Delivery, pp. 255-260, vol. 4.
Paradossi et al., “Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications,” Journal of Materials Science: Materials in Medicine, 2003, pp. 687-691, vol. 14.
PCT/US2012/046122 International Search Report dated Jan. 30, 2013.
PCT/US2012/046123 International Search Report dated Jan. 28, 2013.
PCT/US2012/046125 International Search Report dated Jan. 28, 2013.
Reid, Gavin, et al., “Tandem Mass spectrometry of ribonuclease A and B: N-linked glycosylation site analysis of whole protein ions,” Analytical Chemistry. Feb. 1, 2002, vol. 74, No. 3, pp. 577-583.
Righetti et al, “Elastographic Characterization of HIFU-Induced Lesions in Canine Livers,” 1999, Ultrasound in Med & Bio, vol. 25, No. 7, pp. 1099-1113.
Saad et al., “Ultrasound-Enhanced Effects of Adriamycin Against Murine Tumors,” Ultrasound in Med. & Biol. vol. 18, No. 8, pp. 715-723 (1992).
Related Publications (1)
Number Date Country
20140236049 A1 Aug 2014 US
Continuations (2)
Number Date Country
Parent 12834754 Jul 2010 US
Child 14264732 US
Parent 10944500 Sep 2004 US
Child 12834754 US